Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 December;60(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 December;60(4):308-17

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo
Share

 

REVIEWS  AN UPDATE ON NUCLEAR CARDIOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 December;60(4):308-17

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Novel metrics for risk stratification with nuclear cardiology

Mario PETRETTA 1, Emilia ZAMPELLA 2, Roberta ASSANTE 2, Valentina MERCURIO 1, Wanda ACAMPA 2, Marco SALVATORE 3, Alberto CUOCOLO 2

1 Department of Translational Medical Sciences, Federico II University, Naples, Italy; 2 Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy; 3 SDN Institute for Diagnostic and Nuclear Research, Naples, Italy


PDF


Risk prediction through integration of clinical variables and imaging data into a prognostic model can identify those factors with a high impact on patient outcome. The development of a prognostic model traditionally includes the evaluation of the independent contribution of variables with consideration of covarying factors that may confound risk stratification. Several methods and metrics are available to assess the performance of a prediction model. Traditional measures for binary and survival outcomes include the concordance (C) statistic for discriminative ability, and goodness-of-fit statistics for calibration. Different prognostic approaches, including variants of the C statistic for survival data, reclassification tables, net reclassification improvement, and integrated discrimination improvement have been recently proposed to evaluate the contribution of new markers when they are added to a defined risk model and to evaluate how these variables are able to change the class of risk of the patient and the resulting diagnostic and therapeutic managements. Moreover, decision-analytic measures including decision curves analysis have been introduced to assess the net benefit obtained by making clinical decisions based on model predictions. This review provides an overview of various metrics available for risk stratification using nuclear cardiology procedures, underlying the need of choosing the appropriate prognostic model in order to justify the referral decision.

inizio pagina